Tricuspid atresia primary prevention

Jump to navigation Jump to search

Tricuspid atresia Microchapters

Home

Patient Information

Overview

Pathophysiology

Causes

Differentiating Tricuspid Atresia from other Disorders

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography

Cardiac Catheterization

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Special Scenarios

Pregnancy

Case Studies

Case #1

Tricuspid atresia primary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Tricuspid atresia primary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Tricuspid atresia primary prevention

CDC on Tricuspid atresia primary prevention

Tricuspid atresia primary prevention in the news

Blogs on Tricuspid atresia primary prevention

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Tricuspid atresia primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor-In-Chief:; Sara Zand, M.D.[2] Keri Shafer, M.D. [3] Priyamvada Singh, MBBS [4]; Assistant Editor-In-Chief: Kristin Feeney, B.S. [5]

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Overview

Effective measures for the primary prevention of tricuspid atresia as prenatal screening include fetal sonography between 10-14 weeks of pregnancy for measurement of nuchal translucency thickness, fetal echocardiography between 18-22 weeks of pregnancy

Primary prevention

References

  1. Galindo, A.; Comas, C.; Martínez, J. M.; Gutiérrez-Larraya, F.; Carrera, J. M.; Puerto, B.; Borrell, A.; Mortera, C.; de la Fuente, P. (2009). "Cardiac defects in chromosomally normal fetuses with increased nuchal translucency at 10–14 weeks of gestation". The Journal of Maternal-Fetal & Neonatal Medicine. 13 (3): 163–170. doi:10.1080/jmf.13.3.163.170. ISSN 1476-7058.

Template:WH Template:WS